{"anticipatedPostingDate":"2027-09","denomUnitsSelected":"Participants","description":"ORR as per RECIST v1.1 by investigator was defined as the percentage of participants with confirmed CR or PR. CR was defined as disappearance of all lesions including non-target lesions (not just target lesions). Any pathological lymph nodes must have reduction in short axis to\\<10 mm. PR was defined as at least 30% decrease in the sum of diameters of target lesions, taking as reference the baseline sum diameters. For a response to be considered as confirmed, the subsequent response needs to be at least 4 weeks after the initial response.","reportingStatus":"NOT_POSTED","timeFrame":"From first dose till CR/PR or PD or death, whichever occurred first (maximum up to approximately 7.4 years)","title":"ORR Per RECIST v1.1 by Investigator Assessment","type":"SECONDARY"}